Longevity Next

Biomarker

Circulating taurine

Source-reviewed Last reviewed: 2026-10-02

Research Observatory

Evidence Update

Current evidence

Circulating taurine is not supported here as a universal monotonic aging marker.

What changed

Adds longitudinal/cross-sectional discordance, the step-test exception and non-monotonic frailty findings.

What did not change

Association does not measure metabolic flux or predict response to supplementation.

Why it matters

A marker concept should not inherit an intervention's animal lifespan claim.

Main limitation

Cohort/phenotype differences, diet unmeasured in the frailty study, unresolved subgroup denominators.

Next proof

External phenotype-specific replication with dietary and longitudinal characterization.

Evidence reviewed through

Evidence release LNPG-REL-20261002-002

Sources

  1. Experimental Evidence Against Taurine Deficiency as a Driver of Aging in Humans.

    Source type primary_research_publication Publication date 2025-08-11

    What this source establishes Compares taurine observations in active and inactive men, adding context to human age associations.

    Important limitation Activity and cohort differences limit inference; observational comparisons cannot establish supplementation benefit.

    Evidence access Relevant full-text sections reviewed.

  2. Is taurine an aging biomarker?

    Source type primary_research_publication Publication date 2025-06-05

    What this source establishes Reports findings inconsistent with a universal age-related decline in circulating taurine.

    Important limitation Age associations do not test whether taurine supplementation benefits humans; review was abstract-level.

    Evidence access Abstract reviewed.

  3. Frailty phenotype reveals heterogeneity in aging and distinct taurine associations.

    Source type primary_research_publication Publication date 2026-02-10

    What this source establishes Reports frailty-specific taurine associations that differ across human subgroups.

    Important limitation Subgroup associations do not establish a universal monotonic aging marker or a causal treatment benefit.

    Evidence access Relevant full-text sections reviewed.

Summary

Circulating taurine is not supported here as a universal monotonic aging marker.

Intelligence Take

A marker concept should not inherit an intervention's animal lifespan claim.

Limitations

Cohort/phenotype differences, diet unmeasured in the frailty study, unresolved subgroup denominators.

Opens in a new tab